Change of company name of Singapore share transfer agent
Filed with HKEX · Stock code 867 · · 1 page · English
Summary by 6ix AI
China Medical System Holdings Ltd. announces a change of name for its Singapore share transfer agent. The new name will be effective from a specified date in the future. The address of the share transfer agent will remain the same.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
China Medical System Holdings Ltd. on 6ix
Earlier from China Medical System
- Voluntary and Business Update Announcement Approval of Drug Clinical Trials for Systemic Lupus Erythematosus of Innovative Drug Highly Selective TYK2 Inhibitor CMS-D001
- CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against Rabies, Issued in China
- CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)
- CMS's (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions
- CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®
Later from China Medical System
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Voluntary and Business Update Announcement New Drug Application of Ruxolitinib Phosphate Cream Approved in Singapore
- Next Day Disclosure Return
Follow China Medical System into a list and get an email when it puts out news.
Follow China Medical System